William S. Marth is CEO & President at ALBANY MOLECULAR RESEARCH INC (AMRI). They have made 9 open-market trades across 1 company since 2012, most recently 2017-08-31.
CIK 0001549936
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
9 open-market purchases totalling $2.4M since 2012, never a sale. Across 9 scored buys the stock is down 0.4% at ninety days, and 1.3 points behind the S&P over the same stretch.
9 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| AMRI | 503,416 | $10.9M |
Shares reported on the most recent Form 4, priced at the 2017-09-05 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 11% | 11% | 11% |
| Avg Move | -9.8% | -1.2% | -0.4% |
| Alpha | -4.8% | -1.5% | -1.3% |
| Scored | 9 | 9 | 9 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AMRI | BUY | 2016-05-16 | 2016-05-16 | $12.86 | $161K | +8.6% | +9.6% | +16.2% |
| AMRI | BUY | 2015-06-04 | 2015-06-08 | $19.98 | $200K | -12.1% | -2.5% | -2.5% |
| AMRI | BUY | 2015-03-05 | 2015-03-06 | $17.70 | $354K | -12.1% | -2.5% | -2.5% |
| AMRI | BUY | 2014-11-10 | 2014-11-10 | $17.01 | $510K | -12.1% | -2.5% | -2.5% |
| AMRI | BUY | 2014-05-12 | 2014-05-13 | $15.40 | $462K | -12.1% | -2.5% | -2.5% |
| AMRI | BUY | 2013-12-03 | 2013-12-04 | $10.75 | $323K | -12.1% | -2.5% | -2.5% |
| AMRI | BUY | 2013-11-22 | 2013-11-22 | $11.57 | $231K | -12.1% | -2.5% | -2.5% |
| AMRI | BUY | 2013-06-03 | 2013-06-06 | $10.23 | $102K | -12.1% | -2.5% | -2.5% |
| AMRI | BUY | 2012-12-03 | 2012-12-04 | $5.00 | $50K | -12.1% | -2.5% | -2.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.